Pesquisas alternativas:
drug disease » drug release (Expandir a Pesquisa)
develop them » develop type (Expandir a Pesquisa)
de develop » de developp (Expandir a Pesquisa), e develop (Expandir a Pesquisa), bse develop (Expandir a Pesquisa)
we develop » _ develop (Expandir a Pesquisa), mice develop (Expandir a Pesquisa), help develop (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
develop them » develop type (Expandir a Pesquisa)
de develop » de developp (Expandir a Pesquisa), e develop (Expandir a Pesquisa), bse develop (Expandir a Pesquisa)
we develop » _ develop (Expandir a Pesquisa), mice develop (Expandir a Pesquisa), help develop (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa)
41
Por Kenyon, Nicholas J., Bratt, Jennifer M., Lee, Joyce, Luo, Juntao, Franzi, Lisa M., Zeki, Amir A., Lam, Kit S.
Publicado em 2013
“...Nanocarriers can deliver a wide variety of drugs, target them to sites of interest, and protect...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
42
Por Kitoh, Hiroshi, Achiwa, Masataka, Kaneko, Hiroshi, Mishima, Kenichi, Matsushita, Masaki, Kadono, Izumi, Horowitz, John D, Sallustio, Benedetta C, Ohno, Kinji, Ishiguro, Naoki
Publicado em 2013
“... of heterotopic bones in fibrodysplasia ossificans progressiva (FOP). By the drug repositioning strategy, we...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
43
Por Vitetta, Ellen S., Smallshaw, Joan E., Coleman, Elaine, Jafri, Hasan, Foster, Callie, Munford, Robert, Schindler, John
Publicado em 2006
“..., and five of five in the high-dose group. These results justify further development of the vaccine....”Publicado em 2006
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
44
Por Kim, Sun, Oh, In-Jae, Park, Seo-Yeon, Song, Jang-Hyeon, Seon, Hyun-Ju, Kim, Yun-Hyeon, Yoon, Seong-Hoon, Yu, Jin-Yeong, Lee, Bo-Ram, Kim, Kyu-Sik, Kim, Young-Chul
Publicado em 2014
“... the patients with lung cancer who developed treatment-related pulmonary toxicities, we initially selected those...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
45
Por Samantaray, Sweta, Correia, Joao N., Garelnabi, Mariam, Voelz, Kerstin, May, Robin C., Hall, Rebecca A.
Publicado no Int J Antimicrob Agents (2016)
“.... Here we report an attempt to address this limitation by using a fluorescence-based drug screening...”Publicado no Int J Antimicrob Agents (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
46
“... such as aberrant crypt foci, which may require shorter periods of drug administration; and the development...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
47
Por Morenna Ramos e Oliveira, Murillo Gonçalves Santos, Débora Alves Aude, Rodrigo Moreira e Lima, Norma Sueli Pinheiro Módolo, Lais Helena Navarro
Publicado em 2019-03-01
“... in single-dose. However, high-dose and repeated administration of drugs significantly increase the risk...”Publicado em 2019-03-01
Obter o texto integral
Artigo
48
“...) and conducted structured reviews of them. We coded and analyzed the strategic goals of each off-label marketing...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
49
“... Obstructive Pulmonary Disease -- Statistical Graphics in Late-Stage Drug Development -- Graphical Data...”
Obter o texto integral
Obter o texto integral
Livro
50
Por Martinez, Terina N, Chen, Xi, Bandyopadhyay, Sibali, Merrill, Alfred H, Tansey, Malú G
Publicado em 2012
“... disease (PD) in part because their oxidative environment in the substantia nigra (SN) may render them...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
51
“...-infected patients. In this study, we aimed to compare drug-induced side effects developing in patients...”
Obter o texto integral
Obter o texto integral
Artigo
52
Por Hui Zhang, Zhe Zhu, Jun Li, Yan-Ping Gu, Qiong-Ying Yuan, Jiang Han, Wu-Jun Xiong, Yong-Kun Wang, Cong-Jun Wang
Publicado em 2012-08-01
“...Oxidative stress is involved in the development and progression of disease. Because sodium...”Publicado em 2012-08-01
Obter o texto integral
Artigo
53
Por Delbosc, Sandrine, Haloui, Mounsif, Louedec, Liliane, Dupuis, Morgan, Cubizolles, Myriam, Podust, Vladimir N, Fung, Eric T, Michel, Jean-Baptiste, Meilhac, Olivier
Publicado em 2008
“... group and a group receiving low-dose N(Ω)-nitro-L-arginine methyl ester (L-NAME), a hypertensive drug...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
54
“... the disease is a type of cancer. However, we can gain some insight into how this can be done by looking back...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
55
Por Dave N. T. Aryee, Valerie Fock, Utkarsh Kapoor, Branka Radic-Sarikas, Heinrich Kovar
Publicado em 2022-04-01
“... include dose-intensified chemo- and radiotherapy, as well as surgery. Despite these strategies, patients...”Publicado em 2022-04-01
Obter o texto integral
Artigo
56
“...Type 1 diabetes (T1D) is a prototypic organ-specific autoimmune disease resulting from...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
57
Por S. V. Minenko, Yu. V. Larina, V. V. Ptushkin, N. K. Khuazheva, V. V. Lunin, T. N. Perestoronina, E. R. Biyachuev, A. V. Pshonkin, S. V. Semochkin, Zh. V. Sheikh, V. N. Yakovlev, V. G. Alekseev
Publicado em 2014-07-01
“... malignant CNS diseases. Historically, PLCNS treated with radiotherapy, but the majority of patients had...”Publicado em 2014-07-01
Obter o texto integral
Artigo
58
Por Makidon, Paul E., Nigavekar, Shraddha S., Bielinska, Anna U., Mank, Nicholas, Shetty, Abhishek M., Suman, Julie, Knowlton, Jessica, Myc, Andrzej, Rook, Trent, Baker, James R.
Publicado em 2010
“... of nanoemulsion-based vaccines. In addition, we have determined the efficiency of delivering them using...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
59
Por Goldbach-Mansky, Raphaela, Lee, Jennifer, McCoy, Angela, Hoxworth, Joseph, Yarboro, Cheryl, Smolen, Josef S, Steiner, Günter, Rosen, Antony, Zhang, Cindy, Ménard, Henri A, Zhou, Zhi Jie, Palosuo, Timo, Van Venrooij, Walther J, Wilder, Ronald L, Klippel, John H, Schumacher, H Ralph, EI-Gabalawy, Hani S
Publicado em 2000
“.... There continues to be uncertainty as to what stage of the disease each of these autoantibodies develop...”Publicado em 2000
Obter o texto integral
Obter o texto integral
Artigo
60
Por Jain, Preetesh, Kantarjian, Hagop, Jabbour, Elias, Gonzalez, Graciela Nogueras, Borthakur, Gautam, Pemmaraju, Naveen, Daver, Naval, Gachimova, Evguenia, Ferrajoli, Alessandra, Kornblau, Steven, Ravandi, Farhad, O’Brien, Susan, Cortes, Jorge
Publicado no Lancet Haematol (2015)
“... enrolled before July 25, 2013, were given a starting dose of 45 mg per day; we lowered this due...”Publicado no Lancet Haematol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo